Browsing by Author "Taskoylu, Burcu Yapar"
Now showing items 1-3 of 3
-
Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
Demirci, Umut; Oflazoglu, Utku; Kodaz, Hilmi; Ciltas, Aydin; Kefeli, Umut; Akyol, Murat; Ozturk, Banu; Geredell, Caglayan; Seker, Mehmet Metin; Clhan, Saner; Tastekin, Dldem; Sevinc, Alper; Akinci, Muhammad Bulent; Uysal, Mukremin; Taskoylu, Burcu Yapar; Duran, Ayse Ocak; Yazici, Omer Komi; Karaoglu, Aziz; Benekli, Mustafa; Buyukberber, Suleyman (AMER SOC CLINICAL ONCOLOGY, 2014)… -
Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
Turan, Nedim; Benekli, Mustafa; Unal, Olcun Umit; Unek, Ilkay Tugba; Tastekin, Didem; Dane, Faysal; Algin, Efnan; Ulger, Sukran; Eren, Tulay; Topcu, Turkan Ozturk; Turkmen, Esma; Babacan, Nalan Akgul; Tufan, Gulnihal; Urakci, Zuhat; Ustaalioglu, Basak Oven; Uysal, Ozlem Sonmez; Ercelep, Ozlem Balvan; Taskoylu, Burcu Yapar; Aksoy, Asude; Canhoroz, Mustafa; Demirci, Umut; Dogan, Erkan; Berk, Veli; Balakan, Ozan; Ekinci, Ahmet Siyar; Uysal, Mukremin; Petekkaya, Ibrahim; Ozturk, Selcuk Cemil; Tonyali, Onder; Cetin, Bulent; Aldemir, Mehmet Naci; Helvaci, Kaan; Ozdemir, Nuriye; Oztop, Ilhan; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman (AME PUBL CO, 2015)Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed ... -
Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
Cihan, Sener; Kucukoner, Mehmet; Ozdemir, Nuriye; Dane, Faysal; Sendur, Mehmet Ali Nahit; Yazilitas, Dogan; Urakci, Zuhat; Durnali, Ayse; Yuksel, Sinemis; Aksoy, Sercan; Colak, Dilsen; Seker, Mehmet Metin; Taskoylu, Burcu Yapar; Oguz, Arzu; Isikdogan, Abdurrahman; Zengin, Nurullah (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: The standard therapy for stage I rectum cancer is surgical resection. Currently, there is no strong evidence to suggest that any type of adjuvant therapy is beneficial. The risks of local relapse and distant ...
